[{"NetIncomeLoss_1_Q2_USD":-47010000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":27311000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":14930000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":17858000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":25000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-8374000.0,"Depreciation_2_Q2_USD":225000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":34000.0,"AssetsCurrent_0_Q2_USD":466991000.0,"PrepaidExpenseAndOtherAssets_0_Q2_USD":4214000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":6738718.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":488000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":129000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":135000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":132700000.0,"CommonStockSharesIssued_0_Q2_shares":49103066.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":422912000.0,"Assets_0_Q2_USD":520428000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":-16000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-28000.0,"ShareBasedCompensation_2_Q2_USD":15850000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":1471000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"OperatingLeaseLiability_0_Q2_USD":1952000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-28000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":49466000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":32091000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":2006000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":48326764.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":48422921.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":2975000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-38000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-41000.0,"CommonStockValue_0_Q2_USD":5000.0,"InvestmentIncomeNet_2_Q2_USD":438000.0,"InvestmentIncomeNet_1_Q2_USD":211000.0,"IncreaseDecreaseInOtherCurrentAssets_2_Q2_USD":217000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":488000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":507500000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-76813000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-47038000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":2554000.0,"OtherAssetsNoncurrent_0_Q2_USD":2219000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":84571000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":701000.0,"Liabilities_0_Q2_USD":23845000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":-33000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-16000.0,"EquityMethodInvestments_0_Q2_USD":3451000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":574000.0,"LitigationSettlementExpense_2_Q2_USD":0.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-586000.0,"OtherOperatingActivitiesCashFlowStatement_2_Q2_USD":0.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":59000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":15850000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":8795000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-54632000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":48326764.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":48422921.0,"MarketableSecuritiesNoncurrent_0_Q2_USD":44706000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":1297000.0,"LiabilitiesCurrent_0_Q2_USD":23013000.0,"AccountsPayableCurrent_0_Q2_USD":3904000.0,"NonoperatingIncomeExpense_2_Q2_USD":400000.0,"NonoperatingIncomeExpense_1_Q2_USD":170000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":85136000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":488000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":829000.0,"IncomeLossFromContinuingOperationsPerDilutedShare_2_Q2_USD":-1.59,"IncomeLossFromContinuingOperationsPerDilutedShare_1_Q2_USD":-0.97,"AdditionalPaidInCapital_0_Q2_USD":691953000.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":1025000.0,"NetIncomeLoss_2_Q2_USD":-76797000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-28000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":54000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":-16000.0,"IncomeLossFromEquityMethodInvestments_2_Q2_USD":-420000.0,"CommonStockSharesAuthorized_0_Q2_shares":150000000.0,"OperatingIncomeLoss_2_Q2_USD":-76777000.0,"OperatingIncomeLoss_1_Q2_USD":-47021000.0,"PreferredStockValue_0_Q2_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":520428000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":3814000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":1251000.0,"OperatingExpenses_2_Q2_USD":76777000.0,"OperatingExpenses_1_Q2_USD":47021000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":131000.0,"StockholdersEquity_0_Q2_USD":496583000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":177000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":422887000.0,"IncomeLossFromContinuingOperationsPerBasicShare_2_Q2_USD":-1.59,"IncomeLossFromContinuingOperationsPerBasicShare_1_Q2_USD":-0.97,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-195400000.0,"MarketableSecurities_0_Q2_USD":378206000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-62518000.0,"CommonStockSharesOutstanding_0_Q2_shares":49103066.0,"RestrictedCashNoncurrent_0_Q2_USD":565000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":140897000.0,"PaymentsToAcquireEquityMethodInvestments_2_Q2_USD":0.0,"IncomeLossFromEquityMethodInvestments_1_Q2_USD":-159000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":1101000.0,"Ticker":"SWTX","CIK":"1773427","name":"SPRINGWORKS THERAPEUTICS, INC.","OfficialName":"SpringWorks Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"2504354261.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210804"}]